2023
DOI: 10.1155/2023/6993615
|View full text |Cite
|
Sign up to set email alerts
|

Antibody-Positive Autoimmune Encephalitis and Paraneoplastic Neurological Syndrome: Epidemiology and Outcome of Neuronal Antibody Testing in Sweden

Abstract: Objective. To estimate the 5-year incidence rate of autoimmune encephalitis (AE) and paraneoplastic neurological syndrome (PNS) in Sweden. Methods. All patients who were tested for a neuronal antibody in Sweden between 2015 and 2019 were included. Patients in Healthcare region Mid Sweden (population 2.1 million) were invited to participate in a case ascertainment substudy. AE and PNS cases were defined using established diagnostic criteria. Crude and age-adjusted incidence rates of AE and PNS in Healthcare reg… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…Considering that the population of North Karelia is nearly entirely Caucasian, this difference in ethnic backgrounds might explain the difference in incidence. Indeed, recent data from Sweden suggest an annual incidence of 0.3/100,000 person-years for autoimmune encephalitis and paraneoplastic neurological syndrome with a tendency to increase during the study period (2015-2019) [18]. Recent data from Denmark show an incidence of 0.17/100,000 for NMDAR encephalitis alone [19], suggesting that 0.3 certainly is too low and 0.6/100,000 is more likely to reflect true occurrence rate.…”
Section: Discussionmentioning
confidence: 99%
“…Considering that the population of North Karelia is nearly entirely Caucasian, this difference in ethnic backgrounds might explain the difference in incidence. Indeed, recent data from Sweden suggest an annual incidence of 0.3/100,000 person-years for autoimmune encephalitis and paraneoplastic neurological syndrome with a tendency to increase during the study period (2015-2019) [18]. Recent data from Denmark show an incidence of 0.17/100,000 for NMDAR encephalitis alone [19], suggesting that 0.3 certainly is too low and 0.6/100,000 is more likely to reflect true occurrence rate.…”
Section: Discussionmentioning
confidence: 99%
“…The study population consisted of 37 patients recruited from our previous epidemiological study of AE and PNS (Kosek et al, 2023), in which all patients in Healthcare region Mid Sweden who tested positive for a neuronal antibody between 2015 and 2019 were included.…”
Section: Study Populationmentioning
confidence: 99%